The quantum sector faces a perfect storm of depressed tech markets, lengthening timelines to revenue and unwinding hype. The sector’s long-term potential remains unbound, but startups, investors and governments face a period of challenge. With challenge comes opportunity. The post Navigating the quantum storm appeared first on Fact Based Insight....
A short report has placed a spotlight on IonQ, a quantum computing champion. This should not deflect long term interest in this or other quantum technologies. The post Weathering the First Quantum Short appeared first on Fact Based Insight....
2022 will be a test for the herd of quantum unicorns that has now formed. Which way will the market turn? Expectations on when new algorithms and software will be able to delivery genuine quantum advantage differ widely. The long term importance of the Quantum Internet as a destination for...
The GTN team are united by a mission to a disentangle the quantum challenges in drug discovery to get innovative and effective medicines to patients faster.
We have an amazing interdiciplinary team whose expertise includes Machine Learning, Quantum Physics and Computational Chemistry.
Bringing a single new drug to the market costs $2.9bn, often delivering an intervention that barely differs from those already in the market.
At GTN they are searching the astronomically large space of drug-like molecules with their unique patented technology, Generative Tensorial Networks. Their software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, halving development costs and discovering molecules entirely hidden from view.